Calling ISA investors! 2 FTSE 100 dividend growth stocks I’d buy before April’s deadline

Looking to build your stocks and shares ISA before the tax year expires? These FTSE 100 (INDEXFTSE: UKX) firms could be just what you’re seeking.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The cut-off date for investors to maximise their ISA allowance for the 2018/2019 tax year is almost upon us.

If you haven’t yet made the most that this tax-efficient investment product has to offer, you’ve just over a month to do so. Not much time, sure, so let me give you a helping hand by suggesting two great FTSE 100 shares you should consider buying before April 6.

Profits treble!

Hiscox (LSE: HSX) is a company I’d be happy to load up on right now. It didn’t get off to the best of starts following its ascension to the Footsie in early December, but the insurance giant has fought back in February, its share price up 11% in the month to date.

And brilliant full-year results released this week suggest it can continue its recent revival. The insurance market can be best described as challenging, but Hiscox has remained remarkably resilient despite big claims bills and volatile markets. Gross premiums written boomed 15% in 2018 to $3.8bn, and pre-tax profits subsequently more than trebled year-on-year to $137.4m.

In particular, the company’s thriving retail business provides plenty of reason for celebration. It commented that “we are growing well in our chosen retail segments, and our small market shares mean the size of the opportunity in retail remains immense.” Retail revenues have detonated in recent years and its growing position in the huge US marketplace leaves plenty of sales potential in the coming years.

City analysts certainly reckon Hiscox has plenty more in the bag and are tipping a 156% earnings uplift in 2019 alone, a reading that leaves it trading at dirt-cheap levels, in this case on a sub-1 PEG reading of 0.1.

This isn’t the only cause for celebration, though. With profits powering higher, the number crunchers are anticipating more chunky dividend growth, to 44.4 US cents per share, from 41.9 cents in 2018. A subsequent yield of 2.1% might not be the biggest on the market. But it’s still a white-hot income pick in my book, given the prospect of strong and sustained dividend expansion stretching long into the future.

Stateside star

Another FTSE 100 share worth buying ahead of the upcoming ISA deadline is Experian (LSE: EXPN). It’s  making the headlines today after binning its planned merger with ClearScore on fears that the Competition and Markets Authority would block the move.

I’ve championed the credit score providers before on account off booming revenues in its North American marketplace and I was pleased, therefore, to see that January’s trading update showed improving momentum here. Organic revenues in this critical marketplace rose 12% between October and July, up from 10% in the half-year period.

City analysts are expecting earnings at the firm to rise 4% in fiscal 2019, leading to predictions of a 48 US-cent-per-share dividend, up from 44.75 cents last year.

A consequent yield of 1.8% may be healthy rather than spectacular though. With profits expected to keep booming (and by double-digit percentages in the next couple of years too), like Hiscox, I believe it’s a great income share to buy on expectation of big dividend increases in the years ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Experian. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Down 53% in a year! I reckon this oversold FTSE 100 stock is now ripe for a comeback

This FTSE 100 stock has fallen out of fashion with investors, but Harvey Jones reckons the sell-off has gone too…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

How much second income would I get if I put £10k into dirt cheap Centrica shares?

Centric shares have been looking incredibly cheap despite rocketing in recent years. Harvey Jones wonders whether this is an opportunity…

Read more »

artificial intelligence investing algorithms
Investing Articles

If I’d invested £10k in AstraZeneca shares three months ago here’s what I’d have now

Harvey Jones is kicking himself for failing to buy AstraZeneca shares before the took off. Is there still a decent…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How I’d find shares to buy for an early retirement

Christopher Ruane explains some of the factors he considers when looking for shares to buy that could potentially help him…

Read more »

Investing Articles

Why I’d snap up bargain UK shares to try and build wealth

Christopher Ruane explains how he hopes to find high-quality UK shares selling at attractive prices, to help him build wealth…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

Here’s how I’d target a £2k annual second income from a £20k Stocks & Shares ISA

Our writer explains how he’d try to earn thousands of pounds annually in dividends by investing a £20k ISA in…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Investing Articles

The £20k Stocks and Shares ISA might be one of the better things about living in the UK

The £20k Stocks and Shares ISA doesn't have many equivalents in other countries. Here's why these accounts can help UK…

Read more »